Showing 201 - 220 results of 2,530 for search '"vaccine"', query time: 0.07s Refine Results
  1. 201
  2. 202

    Neonatal and Infantile Immune Responses to Encapsulated Bacteria and Conjugate Vaccines by Peter Klein Klouwenberg, Louis Bont

    Published 2008-01-01
    “…These and several other approaches in current vaccine development will be discussed.…”
    Get full text
    Article
  3. 203

    Diarrheal Diseases Hospitalization in Yemen before and after Rotavirus Vaccination by Mohammed Amood AL-Kamarany, Lina Al-Areqi, Abulatif Mujally, Fawzya Alkarshy, Arwa Nasser, Aisha O. Jumaan

    Published 2016-01-01
    “…The study aims to assess the impact of rotavirus vaccine introduction on diarrheal diseases hospitalization and to identify the rotavirus genotypes most prevalent before and after vaccine introduction among children ≤ 5 years of age. …”
    Get full text
    Article
  4. 204
  5. 205

    Meningococcal B Vaccination (4CMenB) in Infants and Toddlers by Susanna Esposito, Claudia Tagliabue, Samantha Bosis

    Published 2015-01-01
    “…The three purified protein conjugate vaccines currently available target serogroups A, C, W, and Y. …”
    Get full text
    Article
  6. 206

    Postinfluenza Vaccination Idiopathic Thrombocytopenic Purpura in Three Elderly Patients by Joji Nagasaki, Masahiro Manabe, Kentaro Ido, Hiroyoshi Ichihara, Yasutaka Aoyama, Tadanobu Ohta, Yoshio Furukawa, Atsuko Mugitani

    Published 2016-01-01
    “…We report the cases of three elderly patients who developed ITP after receiving influenza vaccinations. The platelet count of an 81-year-old woman fell to 27,000/μL after she received an influenza vaccination. …”
    Get full text
    Article
  7. 207
  8. 208
  9. 209
  10. 210

    Immunogenicity of RSV F DNA Vaccine in BALB/c Mice by Erdal Eroglu, Ankur Singh, Swapnil Bawage, Pooja M. Tiwari, Komal Vig, Shreekumar R. Pillai, Vida A. Dennis, Shree R. Singh

    Published 2016-01-01
    “…With a focus on Th1 immunity, we developed a DNA vaccine containing the native RSV fusion (RSV F) protein and studied its immune response in BALB/c mice. …”
    Get full text
    Article
  11. 211

    Dynamical Models for Infectious Diseases with Varying Population Size and Vaccinations by Peilin Shi, Lingzhen Dong

    Published 2012-01-01
    “…We formulate and discuss models for the spread of infectious diseases with variable population sizes and vaccinations on the susceptible individuals. First, we assume that the susceptible individuals are vaccinated continuously. …”
    Get full text
    Article
  12. 212
  13. 213
  14. 214
  15. 215

    Knowledge, Attitude, and Barriers Influencing Seasonal Influenza Vaccination Uptake by Mazin A. Barry, Khalid I. Aljammaz, Abdulaziz A. Alrashed

    Published 2020-01-01
    “…To measure the influenza vaccine uptake among residents of Riyadh Province, Saudi Arabia, that determines their attitude, knowledge, and beliefs regarding the vaccine. …”
    Get full text
    Article
  16. 216

    Impact of media coverage on the transmission dynamics of TB with vaccines and treatment. by Kumneger Tadesse Mulugeta, Mohammed Yiha Dawed, Shewafera Wondimagegnhu Teklu

    Published 2025-01-01
    “…The main objective of this study is to investigate the impact of media coverage on the transmission dynamics of TB with vaccine and treatment strategy using mathematical model analysis. …”
    Get full text
    Article
  17. 217

    COMPARISON OF REACTOGENICITY AND IMMUNOGENICITY OF LIVE VACCINES AGAINST INFECTIOUS LARYNGOTRACHEITIS by S. A. Pokhvalny, M. S. Kukushkina, V. Yu. Kulakov, N. V. Moroz, N. A. Perevozchikova

    Published 2018-05-01
    “…Regardless of the vaccination route the vaccines decreased the ciliary activity by 5–9 % on Days 3 to 7 post vaccination. …”
    Get full text
    Article
  18. 218
  19. 219
  20. 220

    An Audit of Influenza Vaccination Status in Adults with Inflammatory Bowel Disease by Neeraj Narula, Amit S Dhillon, Usha Chauhan, John K Marshall

    Published 2012-01-01
    “…BACKGROUND Several guidelines recommend influenza vaccination for high-risk patients, including those on immune-suppressing medications (IS).…”
    Get full text
    Article